• About Us
  • Services
  • Process
  • News
  • Contact
BioPortUSA
  • About Us
    • Our Team
    • Advisory Board
    • Partners
    • Process
    • Client Experience
  • Services
    • Market Assessment
    • Market Commercialization
    • Market Launchpad
  • Process
  • News
    • Events
  • Contact
  • About Us
    • Our Team
    • Advisory Board
    • Partners
    • Process
    • Client Experience
  • Services
    • Market Assessment
    • Market Commercialization
    • Market Launchpad
  • Process
  • News
    • Events
  • Contact
13 Aug

BioPort adds Two new clients in the Fight against Covid-19

#

BioPortUSA is extremely excited to announce the addition of two new clients who are both involved in the fight against Covid-19. Protection Impuls with offices in Frankfurt, Germany and Orlando, FL is the largest provider of face shields in all of Europe. Based on their success with face shields they have now expanded into the manufacturing of 3-ply surgical masks and much sought after N95 Respirators. BioPort has been hired to help Protection Impuls commercialize their products in the USA. This includes assisting with regulatory registrations, sales & marketing. We have also been asked to assist with identifying accounting and insurance resources. “With BioPort we have the perfect partner to help us get our products introduced into the USA in a timely and cost effective manner states Michael Müller, CEO of the Protection International the U.S. subsidiary of Protection Impuls. 

The second client that BioPort has brought on to help with the fight against the Coronavirus is Digital Diagnostics. This German company has developed the World’s first 5 minute rapid Covid-19 test.  Mark Lesselroth, CEO of BioPort stated that “Digid’s test will be a game changer in terms of helping bring the U.S. Economy back. Imagine within five minutes you can test whether you are positive or not for the Coronavirus.” The initial work that BioPort was hired for involves getting regulatory approval for a test that will take place at point of care. If all goes well, they plan on rolling out a take home test in the first half of 2021.

Visit

Protection Impuls and Digital Diagnostics

Latest Articles
#
Navigating Health Tech Across Boarders
Apr 29, 2025, 10:33 AM
Navigating the Evolving Regulatory Landscape
Apr 22, 2025, 12:21 PM
Unlocking Success in MedTech: A Powerful Partnership for Growth
Jan 9, 2025, 2:39 PM

Social Media

  • Twitter
  • LinkedIn

About BioPortUSA   

BioPort USA

The Gateway For Life Sciences Into The United States

Contact

United States

Mark Lesselroth, CEO

mark(at)bioportusa.com

+1 315 569 0642

©2017—2025 BioPortUSA All rights reserved.

About Us   Services    Process    Contact    Privacy